TY  - JOUR
T1  - Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al.
TT  - İnflamatuvar Bağırsak Hastalığında Komplikasyonların Bir Göstergesi Olarak Fekal Kalprotektin: Erkut ve Arkadaşlarının Makalesi Üzerine Bir Yorum
AU  - Başpınar, Batuhan
AU  - Güven, İbrahim Ethem
PY  - 2025
DA  - May
Y2  - 2025
DO  - 10.16899/jcm.1582362
JF  - Journal of Contemporary Medicine
JO  - J Contemp Med
PB  - Rabia YILMAZ
WT  - DergiPark
SN  - 2667-7180
SP  - 144
EP  - 145
VL  - 15
IS  - 3
LA  - en
AB  - Abstract is not required for letter to editor. Abstract is not required for letter to editor.
KW  - Fecal calprotectin
KW  - inflammatory bowel disease
KW  - complications
KW  - acute phase reactants
N2  - Abstract is not required for letter to editor.Abstract is not required for letter to editor.
CR  - 1.	Erkut M, Ozkaya E, Fidan S, Cosar AM. Fecal Calprotectin at the Time of Diagnosis May Indicate the Presence of Complications in Inflammatory Bowel Disease. J Contemp Med. 2024;14(1):1-8.
2.	Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99:1051-62.
3.	Goldstone RN, Steinhagen RM. Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am.2019;99:1141-50.
4.	Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56:307-20.
5.	Sipponen T, Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:74-80.
UR  - https://doi.org/10.16899/jcm.1582362
L1  - https://dergipark.org.tr/tr/download/article-file/4353250
ER  -